Related Experiment Video

Updated: Jun 12, 2026

MicroRNA-based Regulation of Picornavirus Tropism
09:05

MicroRNA-based Regulation of Picornavirus Tropism

Published on: February 6, 2017

Impact of microRNAs for pathogenesis and treatment of hepatitis C virus infection

S Pfeffer1, T F Baumert

  • 1Architecture et réactivité de l'ARN, université de Strasbourg, institut de biologie moléculaire et cellulaire du CNRS, 15 rue René-Descartes, Strasbourg, France. spfeffer@unistra.fr

Gastroenterologie Clinique Et Biologique
|June 12, 2010
PubMed

Insights

MicroRNAs (miRNAs) offer a new therapeutic avenue for liver disease. Targeting miR-122 with antagonists suppressed hepatitis C virus (HCV) in chimpanzees, showing promise for novel antiviral treatments.

Area of Science:

  • Molecular Biology
  • Virology
  • Hepatology

Background:

  • RNA interference (RNAi) and microRNAs (miRNAs) are crucial in cellular processes and disease pathogenesis.
  • Hepatitis C virus (HCV) manipulates host miRNAs, notably recruiting miR-122 to enhance viral replication.
  • miR-122 dysregulation is linked to HCV infection outcomes and therapeutic response.

Purpose of the Study:

  • To review the role of miRNAs in the pathogenesis of liver disease, particularly HCV infection.
  • To explore the therapeutic potential of targeting miRNAs, specifically miR-122, for HCV treatment.

Main Methods:

  • Literature review of recent discoveries on miRNA involvement in HCV pathogenesis and treatment.
  • Analysis of studies investigating miR-122's role in HCV replication and its association with treatment response.
  • Examination of preclinical data on miR-122 antagonists in HCV-infected animal models.

Main Results:

  • miR-122 plays a complex role in HCV pathogenesis, influencing treatment response.
  • Antiviral intervention targeting miR-122 in chimpanzees led to suppression of HCV viremia.
  • miRNA-based therapy demonstrated a prolonged virological response, suggesting a high barrier to resistance.

Conclusions:

  • MicroRNAs, particularly miR-122, represent a significant target for novel antiviral therapies against HCV.
  • miRNA-based interventions hold promise for effective and durable treatment of chronic HCV infection.
  • Further research into miRNA therapeutics could revolutionize the management of liver diseases.

More Related Videos

A Protocol for Analyzing Hepatitis C Virus Replication13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Human Virome01:26

Human Virome

The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...